Tumor Niche Network-Defined Subtypes Predict Immunotherapy Response of Esophageal Squamous Cell Cancer.
Tumor Niche Network-Defined Subtypes Predict Immunotherapy Response of Esophageal Squamous Cell Cancer.
复制标题
肿瘤生态位网络定义的亚型预测食管鳞状细胞癌的免疫治疗反应。
DOI:
10.1101/2023.02.15.528539
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Park,Jae-Il
中科院分区:
文献类型:
--
作者:
Ko,Kyung-Pil;Zhang,Shengzhe;Huang,Yuanjian;Kim,Bongjun;Zou,Gengyi;Jun,Sohee;Zhang,Jie;Martin,Cecilia;Dunbar,KarenJ;Efe,Gizem;Rustgi,AnilK;Zhang,Haiyang;Nakagawa,Hiroshi;Park,Jae-Il
Despite the promising outcomes of immune checkpoint inhibitors (ICIs), resistance to ICI presents a new challenge. Therefore, selecting patients for specific ICI applications is crucial for maximizing therapeutic efficacy. Herein, we curated 69 human esophageal squamous cell cancer (ESCC) patients' tumor microenvironment (TME) single-cell transcriptomic datasets to subtype ESCC. Integrative analyses of the cellular network and transcriptional signatures of T cells and myeloid cells define distinct ESCC subtypes characterized by T cell exhaustion, and interleukin (IL) and interferon (IFN) signaling. Furthermore, this approach classifies ESCC patients into ICI responders and non-responders, as validated by whole tumor transcriptomes and liquid biopsy-based single-cell transcriptomes of anti-PD-1 ICI responders and non-responders. Our study stratifies ESCC patients based on TME transcriptional network, providing novel insights into tumor niche remodeling and potentially predicting ICI responses in ESCC patients.